These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 38173050)

  • 1. Poly(lactic-co-glycolic) Acid (PLGA) Nanoparticles and Transdermal Drug Delivery: An Overview.
    Kumar L; Kukreti G; Rana R; Chaurasia H; Sharma A; Sharma N; Komal
    Curr Pharm Des; 2023; 29(37):2940-2953. PubMed ID: 38173050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micelle-templated, poly(lactic-
    Nabar GM; Mahajan KD; Calhoun MA; Duong AD; Souva MS; Xu J; Czeisler C; Puduvalli VK; Otero JJ; Wyslouzil BE; Winter JO
    Int J Nanomedicine; 2018; 13():351-366. PubMed ID: 29391794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomedical applications of PLGA nanoparticles in nanomedicine: advances in drug delivery systems and cancer therapy.
    Narmani A; Jahedi R; Bakhshian-Dehkordi E; Ganji S; Nemati M; Ghahramani-Asl R; Moloudi K; Hosseini SM; Bagheri H; Kesharwani P; Khani A; Farhood B; Sahebkar A
    Expert Opin Drug Deliv; 2023; 20(7):937-954. PubMed ID: 37294853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual tumor-targeted poly(lactic-
    Chen J; Wu Q; Luo L; Wang Y; Zhong Y; Dai HB; Sun D; Luo ML; Wu W; Wang GX
    Int J Nanomedicine; 2017; 12():5745-5760. PubMed ID: 28848351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, characterization, and evaluation of paclitaxel loaded in six-arm star-shaped poly(lactic-co-glycolic acid).
    Chen Y; Yang Z; Liu C; Wang C; Zhao S; Yang J; Sun H; Zhang Z; Kong D; Song C
    Int J Nanomedicine; 2013; 8():4315-26. PubMed ID: 24235829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fabrication of Poly Lactic-
    Shrestha N; Karve T; Kipping T; Banga AK
    Mol Pharm; 2024 Oct; 21(10):5192-5204. PubMed ID: 39255036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyrene™ as an Alternative Sustainable Solvent for the Preparation of Poly(lactic-co-glycolic acid) Nanoparticles.
    Grune C; Thamm J; Werz O; Fischer D
    J Pharm Sci; 2021 Feb; 110(2):959-964. PubMed ID: 33275992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLGA's Plight and the Role of Stealth Surface Modification Strategies in Its Use for Intravenous Particulate Drug Delivery.
    Sheffey VV; Siew EB; Tanner EEL; Eniola-Adefeso O
    Adv Healthc Mater; 2022 Apr; 11(8):e2101536. PubMed ID: 35032406
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles.
    Malinovskaja-Gomez K; Labouta HI; Schneider M; Hirvonen J; Laaksonen T
    Eur J Pharm Sci; 2016 Jun; 89():154-62. PubMed ID: 27131608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Review on Designing Poly (Lactic-co-glycolic Acid) Nanoparticles as Drug Delivery Systems.
    Naskar S; Das SK; Sharma S; Kuotsu K
    Pharm Nanotechnol; 2021; 9(1):36-50. PubMed ID: 33319695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimizing lornoxicam-loaded poly(lactic-co-glycolic acid) and (polyethylene glycol) nanoparticles for transdermal delivery:
    Qaiser R; Pervaiz F; Noreen S; Hanan H; Shoukat H; Mahmood H; Ashraf MA
    Nanomedicine (Lond); 2024 Jul; 19(16):1471-1485. PubMed ID: 38953843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PLGA-based nanoparticles as cancer drug delivery systems.
    Sadat Tabatabaei Mirakabad F; Nejati-Koshki K; Akbarzadeh A; Yamchi MR; Milani M; Zarghami N; Zeighamian V; Rahimzadeh A; Alimohammadi S; Hanifehpour Y; Joo SW
    Asian Pac J Cancer Prev; 2014; 15(2):517-35. PubMed ID: 24568455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered PLGA nanoparticles: an emerging delivery tool in cancer therapeutics.
    Jain AK; Das M; Swarnakar NK; Jain S
    Crit Rev Ther Drug Carrier Syst; 2011; 28(1):1-45. PubMed ID: 21395514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iontophoretic transdermal delivery using chitosan-coated PLGA nanoparticles for positively charged drugs.
    Takeuchi I; Takeshita T; Suzuki T; Makino K
    Colloids Surf B Biointerfaces; 2017 Dec; 160():520-526. PubMed ID: 29017147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of transdermal vitamin D3 (VD3) delivery system using combinations of PLGA nanoparticles and microneedles.
    Kim HG; Gater DL; Kim YC
    Drug Deliv Transl Res; 2018 Feb; 8(1):281-290. PubMed ID: 29247316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly-(lactic-
    Orekhova A; Palocci C; Chronopoulou L; De Angelis G; Badiali C; Petruccelli V; D'Angeli S; Pasqua G; Simonetti G
    Molecules; 2022 Aug; 27(17):. PubMed ID: 36080191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted delivery of mannosylated-PLGA nanoparticles of antiretroviral drug to brain.
    Patel BK; Parikh RH; Patel N
    Int J Nanomedicine; 2018; 13(T-NANO 2014 Abstracts):97-100. PubMed ID: 29593405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pegylated poly(lactide) and poly(lactide-co-glycolide) nanoparticles: preparation, properties and possible applications in drug delivery.
    Avgoustakis K
    Curr Drug Deliv; 2004 Oct; 1(4):321-33. PubMed ID: 16305394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spermidine-mediated poly(lactic-
    Tang J; Li J; Li G; Zhang H; Wang L; Li D; Ding J
    Int J Nanomedicine; 2017; 12():6687-6704. PubMed ID: 28932114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improving cellular uptake and cytotoxicity of chitosan-coated poly(lactic-
    Van Hees S; Elbrink K; De Schryver M; Delputte PL; Kiekens F
    Nanomedicine (Lond); 2020 Nov; 15(27):2671-2688. PubMed ID: 33112210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.